179 related articles for article (PubMed ID: 10618536)
1. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
Abu-Elyazeed R; Jennings W; Severance R; Noss M; Caplanusi A; Povey M; Henry O
Hum Vaccin Immunother; 2018; 14(11):2624-2631. PubMed ID: 29902133
[TBL] [Abstract][Full Text] [Related]
3. Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose.
Carazo Perez S; De Serres G; Bureau A; Skowronski DM
Clin Infect Dis; 2017 Oct; 65(7):1094-1102. PubMed ID: 28595358
[TBL] [Abstract][Full Text] [Related]
4. A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine.
Shah N; Ghosh A; Kumar K; Dutta T; Mahajan M
Hum Vaccin Immunother; 2024 Dec; 20(1):2302685. PubMed ID: 38236022
[TBL] [Abstract][Full Text] [Related]
5. Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.
Saffar H; Khalifeloo M; Saffar MJ; Abdollahi A; Parsaei MR; Ghorbani GR; Salarvand S; Aarabi M
BMC Infect Dis; 2021 Mar; 21(1):305. PubMed ID: 33765968
[TBL] [Abstract][Full Text] [Related]
6. Measles, mumps, and rubella revaccination in children after completion of chemotherapy and hematopoietic stem cell transplantation: a single-center prospective efficacy and safety analysis.
Wang M; Yuan Q; Deng PF; Fei Y; Zhang H; Zhou F; Chen WJ; Cao Q; Chen J; Gao YJ
World J Pediatr; 2023 Nov; 19(11):1062-1070. PubMed ID: 37087716
[TBL] [Abstract][Full Text] [Related]
7. Shedding of measles vaccine RNA in children after receiving measles, mumps and rubella vaccination.
Washam MC; Leber AL; Oyeniran SJ; Everhart K; Wang H
J Clin Virol; 2024 Aug; 173():105696. PubMed ID: 38823291
[TBL] [Abstract][Full Text] [Related]
8. Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial.
Vittrup DM; Laursen ACL; Malon M; Soerensen JK; Hjort J; Buus S; Svensson J; Stensballe LG
Trials; 2020 Dec; 21(1):1015. PubMed ID: 33303011
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.
Kaaijk P; Gouma S; Hulscher HI; Han WG; Kleijne DE; van Binnendijk RS; van Els CA
Hum Vaccin Immunother; 2015; 11(7):1754-61. PubMed ID: 26047038
[TBL] [Abstract][Full Text] [Related]
10. Genetics and measles, mumps and rubella vaccine response in childhood and adolescence-A systematic review.
Haslund MM; Sørensen JK; Graff Stensballe L
Scand J Immunol; 2023 Jun; 97(6):e13266. PubMed ID: 38157324
[TBL] [Abstract][Full Text] [Related]
11. Application of a fast and cost-effective 'three-in-one' MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience.
Böröcz K; Csizmadia Z; Markovics Á; Farkas N; Najbauer J; Berki T; Németh P
Epidemiol Infect; 2020 Feb; 148():e17. PubMed ID: 32014073
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
Stermole BM; Grandits GA; Roediger MP; Clark BM; Ganesan A; Weintrob AC; Crum-Cianflone NF; Ferguson TM; Macalino GE; Landrum ML
Vaccine; 2011 Apr; 29(16):2874-80. PubMed ID: 21352938
[TBL] [Abstract][Full Text] [Related]
13. Live-attenuated vaccination for measles, mumps, and rubella in pediatric liver transplantation.
Keutler A; Lainka E; Posovszky C
Pediatr Transplant; 2024 Feb; 28(1):e14687. PubMed ID: 38317348
[TBL] [Abstract][Full Text] [Related]
14. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K
Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam.
Brunton JS; Theiler RN; Mehta R; Branda ME; Enninga EAL; Torbenson VE
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766189
[TBL] [Abstract][Full Text] [Related]
16. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.
van den Berg JP; Westerbeek EA; Smits GP; van der Klis FR; Berbers GA; van Elburg RM
PLoS One; 2014; 9(4):e94714. PubMed ID: 24728480
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibody titers against D8 genotype and persistence of measles humoral and cell-mediated immunity eight years after the first dose of measles, mumps, and rubella vaccine in Brazilian children.
Kegele Lignani L; de Vasconcellos Carvalhaes de Oliveira R; Matos Dos Santos E; Antonio Bastos Camacho L; Reis Xavier J; Regina da Silva E Sá G; Mendonça Siqueira M; Marques Vieira da Silva A; Gil Melgaço J; Dos Santos Alves N; de Lourdes de Sousa Maia M; Caetano Prates Melo E
Vaccine; 2024 Mar; 42(8):2065-2071. PubMed ID: 38413280
[TBL] [Abstract][Full Text] [Related]
18. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.
Deeks SL; Lim GH; Simpson MA; Gagné L; Gubbay J; Kristjanson E; Fung C; Crowcroft NS
CMAJ; 2011 Jun; 183(9):1014-20. PubMed ID: 21576295
[TBL] [Abstract][Full Text] [Related]
19. Seropositivity rates for measles, mumps, and rubella IgG and costs associated with testing and revaccination.
Shirts BH; Welch RJ; Couturier MR
Clin Vaccine Immunol; 2013 Mar; 20(3):443-5. PubMed ID: 23345583
[TBL] [Abstract][Full Text] [Related]
20. Measles and rubella immunity in the population of Bhutan, 2017.
Wangchuk S; Nogareda F; Tshering N; Khandu L; Pelden S; Wannemuehler K; Wangdi S; Wangchuk U; Mulders M; Tamang T; Patel MK
Vaccine; 2019 Oct; 37(43):6463-6469. PubMed ID: 31500970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
